Alyeska Investment Group
NUVL icon

Alyeska Investment Group’s Nuvalent NUVL Stock Holding History

Alyeska Investment Group’s Portfolio NUVL Stock Details NUVL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-25,533
Closed -$2.57M – 709
2025
Q4 		$2.57M Sell
25,533
-75,533
-75% -$7.45M 0.01% 509
2025
Q3 		$8.74M Buy
101,066
+51,066
+102% +$4.04M 0.03% 395
2025
Q2 		$3.81M Sell
50,000
-1,303
-3% -$95.3K 0.01% 442
2025
Q1 		$3.64M Sell
51,303
-51,302
-50% -$4.01M 0.01% 384
2024
Q4 		$8.03M Sell
102,605
-12,395
-11% -$1.16M 0.03% 361
2024
Q3 		$11.8M Buy
+115,000
New +$9.54M 0.06% 279

Other funds holding NUVL

DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Alyeska Investment Group's NUVL Position: Q1 2026 in Review

Alyeska Investment Group sold out of Nuvalent (NUVL) in Q1 2026, closing a stake of 25,533 shares — an estimated $2.57M sold.

Alyeska Investment Group first reported a position in NUVL in Q3 2024 and held it in 6 quarters. The position peaked at $11.8M in Q3 2024. 263 funds tracked by Wall St. Rank hold NUVL as of Q1 2026.

  • Alyeska Investment Group reported no remaining Nuvalent position as of Q1 2026 after selling out during the quarter.
  • Alyeska Investment Group sold 25,533 Nuvalent shares in Q1 2026, an estimated $2.57M.
  • Alyeska Investment Group first reported a position in Nuvalent in Q3 2024 and held it in 6 quarters.
  • Alyeska Investment Group's Nuvalent position peaked at $11.8M in Q3 2024.
  • 263 funds tracked by Wall St. Rank held Nuvalent as of Q1 2026.

Based on Alyeska Investment Group's 13F filing for Q1 2026, filed 15 May 2026.